GlassScriptPhysician profile
Robert Iadevaio
NPI 1285613760
$20,254.43
in general payments reported to CMS, 2019-2025
45 companies · $1,621 in 2025
The $1,621 reported for 2025 was more than what 78% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,400 · 2020: $1,408 · 2021: $1,710 · 2022: $1,291 · 2023: $7,590 · 2024: $4,234 · 2025: $1,621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,580 · Food and Beverage: $4,312 · Consulting Fee: $2,500 · Travel and Lodging: $53.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,580.00 |
| Food and Beverage | $4,311.91 |
| Consulting Fee | $2,500.00 |
| Travel and Lodging | $53.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $7,870.43 | 2019-2023 | Intracept |
| Vertos Medical, INC. | $2,500.00 | 2024 | Mild Device Kit |
| Abbott Laboratories | $1,458.52 | 2019-2024 | Eterna, Proclaim |
| Boston Scientific Corporation | $1,399.04 | 2019-2025 | Intracept, General - Pain Management |
| Collegium Pharmaceutical, INC. | $931.23 | 2019-2025 | Belbuca, Xtampza |
| Nevro Corp. | $775.17 | 2019-2024 | Senza |
| Abbvie INC. | $743.98 | 2022-2025 | |
| Medtronic, INC. | $634.08 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Osteocool Rf Ablation System |
| Scilex Pharmaceuticals INC. | $586.03 | 2019-2025 | Ztlido |
| Medtronic USA, INC. | $584.38 | 2019-2020 | |
| Redhill Biopharma INC. | $329.45 | 2020-2022 | |
| Allergan, INC. | $291.13 | 2020-2022 | |
| Intrinsic Therapeutics | $270.38 | 2020-2022 | |
| Globus Medical, INC. | $158.80 | 2025 | Senza |
| Valinor Pharma, LLC | $153.61 | 2023-2025 | Movantik |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Iadevaio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.